Tenpoint Therapeutics
FranceEntry
2022
Hold
4yr
Status
Active
Who owns Tenpoint Therapeutics?
Tenpoint Therapeutics is a French Biotech company, currently owned by AdBio Partners since 2023 and Sofinnova Partners.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Sofinnova PartnersSofinnova Capital X · 2021 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2022 · present
Sofinnova PartnersActive
2022 · present(4yr) · Sofinnova Capital X · 2021 · Life Sciences VC
AdBio PartnersActive
2023 · present(3yr) · AFB Fund II · 2021 · VC
More from Sofinnova Capital X
Other portfolio companies in the same fund.
Germany
Denmark
Spain
UK
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Tenpoint Therapeutics?
Tenpoint Therapeutics is currently owned by AdBio Partners and Sofinnova Partners, through Sofinnova Capital X, since 2023.
When did AdBio Partners and 1 other acquire Tenpoint Therapeutics?
AdBio Partners and 1 other acquired Tenpoint Therapeutics in 2023.
Who has owned Tenpoint Therapeutics over time?
Tenpoint Therapeutics has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital X · since 2022; AdBio Partners · via AFB Fund II · since 2023.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue